The CEO of pharmaceuticals giant Roche said authorities should block the takeover of contract drug manufacturer Catalent by ...

Roche Bros. Supermarkets is selling controlling interest to one of its suppliers. The family-owned retailer that operates 20 stores in Massachusetts entered into agreement with Bozzuto's Inc., a deal ...

The brand came to develop products specifically designed for dermatologists and skin care professionals to treat patients ...

Seventy-two years after the Roche family opened a meat market that grew into a Massachusetts supermarket chain, the family is ...

Karen Lightning-Jones, head of personalised healthcare and strategic partnerships, Roche Products Limited said: “Today's news follows many years of dedication and hard work by our scientists and ...

including any devices which may directly compete with Roche products. Extra financial resources from the acquisition will go toward recruitment, product improvement, and building more ...

With the formation of a new strategic partnership, Dyno Therapeutics is responsible for the development of novel AAV capsids.

Dyno is also entitled to royalties on net sales of commercial products. Dyno specializes in ... In 2020, Dyno signed its first agreement with Roche to help the drug giant and its subsidiary ...

Roche Holding AG is willing to pay more than $1 billion to solve one of the biggest challenges of gene therapy: delivery.

Dyno founder and CEO Eric Kelsic stated: “This new collaboration with Roche, focused on developing next-generation gene ...

While current top products could see new branded and biosimilar threats over the next several years, the combined Roche-Chugai pipeline is robust and promising. Chugai was founded in 1925 and ...

FRANKFURT (Reuters) -The CEO of pharmaceuticals giant Roche said authorities should block the takeover of contract drug manufacturer Catalent by Novo Nordisk's controlling shareholder, as it could hit ...